SAN DIEGO --(BUSINESS WIRE)--Oct. 7, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2021 results after the financial markets close on Wednesday, November 3, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Aug. 30, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: Wells Fargo 2021 Virtual Health Care
SAN DIEGO --(BUSINESS WIRE)--Aug. 4, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2021 and updated its sales guidance for the year ending December 31, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Jul. 29, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the UBS Genomics 2.0 and Medtech Innovations Summit on Thursday, August 12, 2021 at
SAN DIEGO --(BUSINESS WIRE)--Jul. 12, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2021 results after the financial markets close on Wednesday, August 4, 2021 .
SAN DIEGO, Calif. --(BUSINESS WIRE)--Jun. 27, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today presented positive real-world data from ongoing use of the t:slim X2™ insulin pump with Control-IQ® advanced hybrid closed-loop
SAN DIEGO --(BUSINESS WIRE)--Jun. 4, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced data presented this week on real-world use of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology at the 14th
SAN DIEGO --(BUSINESS WIRE)--May 5, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2021 and updated its sales guidance for the year ending December 31, 2021 .
SAN DIEGO --(BUSINESS WIRE)--May 3, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: BofA Securities 2021 Virtual Health Care
SAN DIEGO --(BUSINESS WIRE)--Apr. 6, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2021 results after the financial markets close on Wednesday, May 5, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Mar. 3, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: Barclays Global Healthcare Conference on
SAN DIEGO --(BUSINESS WIRE)--Mar. 1, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jordan Pinsker , MD, to Vice President and Medical Director, effective April 26, 2021 . Dr.
SAN DIEGO --(BUSINESS WIRE)--Feb. 24, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2020 and financial guidance for the year ending December 31, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Feb. 16, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: Citi 2021 Healthcare Services, Medtech,
SAN DIEGO --(BUSINESS WIRE)--Jan. 19, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 results after the financial markets close on Wednesday, February 24, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Dec. 14, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rajwant (Raj) Singh Sodhi as an independent member of its board of directors effective January 1, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Nov. 23, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2™ insulin pump with Control-IQ™ technology. Control-IQ technology is an advanced hybrid
SAN DIEGO --(BUSINESS WIRE)--Nov. 5, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2020 and updated its sales guidance for the year ending December 31, 2020 .
SAN DIEGO --(BUSINESS WIRE)--Oct. 30, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: 29 th Annual Credit Suisse Healthcare
SAN DIEGO --(BUSINESS WIRE)--Oct. 8, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2020 results after the financial markets close on Thursday, November 5, 2020 .
